Effect of Platelet-rich Plasma on the in vitro Proliferation and Osteogenic Differentiation of Human Mesenchymal Stem Cells on Distinct Calcium Phosphate Scaffolds: The Specific Surface Area Makes a Difference
- 8 May 2008
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 23 (2) , 169-188
- https://doi.org/10.1177/0885328207088269
Abstract
The in vitro effect of platelet-rich plasma (PRP) on cell loading, proliferation, and osteogenic differentiation of human mesenchymal stem cells (MSC) is assessed on distinct resorbable and synthetic calcium phosphate scaffolds. A high specific surface area scaffold composed of calcium-deficient hydroxyapatite (CDHA; 48m2/g) is compared with one made out of β-tricalcium phosphate (β-TCP; surface area 2/g). Fivefold concentrated fresh PRP is applied to scaffolds loaded with 2 × 105 MSC (n = 5). These constructs are kept in a medium with osteogenic supplements for 3 weeks. The addition of PRP leads to a higher cell loading efficiency of MSC on CDHA (p = 0.0001), that reaches the values of β-TCP. Proliferation over 21 days is improved by PRP both on CDHA (p = 0.0001) and β-TCP (p = 0.014) compared to MSC/calcium phosphate composites. Without the addition of PRP, CDHA has a lower cell loading efficiency (p= 0.0001) and proliferation (p= 0.001) than β-TCP. The ALP activity is higher in the MSC/ceramics groups than in the monolayer controls (p<0.05). The addition of PRP does not significantly affect ALP activity. However, ALP activity varies considerably within the cell donors and different PRP-pools (p = 0.001), while the cell numbers do not vary within these two parameters. PRP generates a positive effect on the loading efficiency of MSC on the high specific surface scaffold CDHA that thereby reaches the loading efficiency of β-TCP. PRP improved proliferation, but its osteogenic properties on both calcium phosphate scaffolds are weak.Keywords
This publication has 40 references indexed in Scilit:
- Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity andin vivobone formation in calcium phosphate ceramicsPlatelets, 2006
- Induktion von Knochengewebe auf unterschiedlichen Matrizes: Eine In-vitro- und In-vivo-Pilotstudie in der SCID MausZeitschrift für Orthopädie und ihre Grenzgebiete, 2004
- Effects of platelet‐rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical‐size defectsClinical Oral Implants Research, 2004
- Comparative study of β-tricalcium phosphate mixed with platelet-rich plasma versus β-tricalcium phosphate, a bone substitute material in dentistryActa Veterinaria Hungarica, 2003
- Bone Tissue-Engineered Implants Using Human Bone Marrow Stromal Cells: Effect of Culture Conditions and Donor AgeTissue Engineering, 2002
- Wachstumsstimulation von humanen osteoblastenähnlichen Zellen durch Thrombozytenkonzentrate in vitroMund-,Kiefer- und Gesichtschirurgie, 2002
- Evaluation of recombinant human bone morphogenetic protein‐2 as a bone‐graft substitute in a canine segmental defect modelJournal of Orthopaedic Research, 2000
- Patients with Primary Osteoarthritis Show No Change with Ageing in the Number of Osteogenic PrecursorsScandinavian Journal of Rheumatology, 1998
- Single-Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In VivoJournal of Bone and Mineral Research, 1997
- Characterization of cells with osteogenic potential from human marrowBone, 1992